Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Goldman Sachs Analyst Sticks with Sell Rating on Kronos Worldwide Increases Price Target to 9

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Finance_Business (1)
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Goldman Sachs analyst Duffy Fischer is sticking with his Sell rating on Kronos Worldwide (NYSE: KRO) as of March 11, 2024, but has increased the price target to $9 from $8. Fischer’s decision to raise the price target indicates his perspective on the company’s potential performance in the current market environment.

Kronos Worldwide Inc. (KRO) Stock Shows Strong Performance on March 11, 2024

On March 11, 2024, Kronos Worldwide Inc. (KRO) showed strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, KRO demonstrated positive price momentum. The price of KRO shares increased by $0.25 since the market last closed, representing a 2.48% rise. This increase brought the closing price of KRO to $10.34 on March 11, 2024. Kronos Worldwide Inc. is a global producer and marketer of value-added titanium dioxide pigments. Overall, KRO’s stock performance on March 11, 2024, showcases the company’s strong fundamentals and growth prospects. Investors who are looking for a stock with positive price momentum and potential for future growth may consider adding KRO to their portfolio.

Kroger Co. (KRO) Stock Performance Analysis: Revenue Down, Net Loss Improves – March 2024 Update

On March 11, 2024, Kroger Co. (KRO) stock experienced mixed performances based on the latest financial data. According to CNN Money, the company reported a total revenue of $1.67 billion for the past year, which is a 13.66% decrease compared to the previous year. However, the total revenue remained flat at $400.10 million for the last quarter. In terms of net income, Kroger reported a net loss of $49.10 million for the past year, representing a significant decrease of 146.99% compared to the previous year. On the other hand, the net loss improved to $5.30 million for the last quarter, showing a 74.02% increase compared to the previous quarter. Earnings per share (EPS) for Kroger also showed a similar trend. The company reported an EPS of -$0.43 for the past year, which is a 147.15% decrease compared to the previous year. However, the EPS improved to -$0.05 for the last quarter, showing a 74.01% increase compared to the previous quarter. Investors and analysts will closely monitor Kroger’s future performance to see if the company can sustain its positive momentum and continue to improve its financial results.

Tags: KRO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
The Rise of Enterprise Business Intelligence Platforms: Transforming Operations in the Healthcare Sector

Lumen Technologies Launches Consent Solicitation to Finalize Transactions

Aerospace and Defense Market Capitalization

BOS Intelligent Robotics Division Secures 615000 Order from Israeli Defense Client

Finance_Financing

The Importance of Circuit Breakers in Stock Trading

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com